Thyroid Eye Disease Overview

Save information for later
Sign Up

Learn About Thyroid Eye Disease

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top Thyroid Eye Disease Local Doctors?
Elite in Thyroid Eye Disease
Elite in Thyroid Eye Disease
653 N Town Ctr Dr, Suite 512, 
Las Vegas, NV 
Languages Spoken:
English
Accepting New Patients

Raymond Douglas is an Ophthalmologist in Las Vegas, Nevada. Dr. Douglas is rated as an Elite provider by MediFind in the treatment of Thyroid Eye Disease. His top areas of expertise are Thyroid Eye Disease, Graves Disease, Eyelid Drooping, and Ptosis. Dr. Douglas is currently accepting new patients.

Elite in Thyroid Eye Disease
Ophthalmology
Elite in Thyroid Eye Disease
Ophthalmology
178 E 71st St, 
New York, NY 
Languages Spoken:
English

Michael Kazim is an Ophthalmologist in New York, New York. Dr. Kazim is rated as an Elite provider by MediFind in the treatment of Thyroid Eye Disease. His top areas of expertise are Thyroid Eye Disease, Graves Disease, Optic Glioma, Turbinectomy, and Endoscopy.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Thyroid Eye Disease
Elite in Thyroid Eye Disease
Mainz, RP, DE 

George Kahaly practices in Mainz, Germany. Mr. Kahaly is rated as an Elite expert by MediFind in the treatment of Thyroid Eye Disease. His top areas of expertise are Graves Disease, Hyperthyroidism, Thyroid Eye Disease, Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy (APECED), and Thyroidectomy.

What are the latest Thyroid Eye Disease Clinical Trials?
A Phase 3, Randomized, Double-Masked, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Efgartigimod PH20 SC Administered by Prefilled Syringe in Adult Participants With Thyroid Eye Disease

Summary: This study aims to evaluate the efficacy, safety and tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and immunogenicity of efgartigimod PH20 SC in participants with active, moderate-to-severe TED, compared with placebo PH20 SC. After the screening period, eligible participants will be randomized in a 2:1 ratio to receive efgartigimod PH20 SC or placebo PH20 SC, respectively during the ...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase 1/2, Randomized, Double-Masked, Placebo-Controlled, Multicenter Study to Assess the Safety, Pharmacokinetics, and Efficacy of AMG 732 in Healthy Subjects and Subjects With Moderate-to-Severe Active Thyroid Eye Disease

Summary: The primary objective of Part A of this study is to investigate the safety and tolerability of AMG 732 after single subcutaneous (SC) doses. The primary objective of Part B of this study is to investigate the efficacy of AMG 732 in participants with Thyroid Eye Disease (TED) after multiple SC doses.